Skip to main content
International Wound Journal logoLink to International Wound Journal
. 2020 Feb 17;17(3):683–691. doi: 10.1111/iwj.13324

Deep sternal wound infection following cardiac surgery: A comparison of the monolateral with the bilateral pectoralis major flaps

Federico Lo Torto 1, Gianmarco Turriziani 1,, Casella Donato 2, Marco Marcasciano 1, Ugo Redi 1, Manfredi Greco 3, Fabio Miraldi 4, Diego Ribuffo 1
PMCID: PMC7948840  PMID: 32065728

Abstract

Deep sternal wound infections are a serious complication following sternotomy for cardiothoracic surgery. “Conventional” treatment provides debridement and secondary closure or closed catheter irrigation. The combination of the Negative Pressure Therapy with flap coverages is an accepted technique and one or both Pectoralis Major muscles could be chosen. A multistep protocol was adopted. One hundred and sixty seven patients were treated with the combination of Negative Pressure Therapy with the Pectoralis Major muscle flap: 86 monolateral flap and 81 bilateral flap reconstruction. The main complications (hematoma, seroma, dehiscence, and re‐infection), the need for re‐intervention, mortality rates, Intensive Care Unit, and hospitalisation time were assessed. The mono‐pectoralis group had fewer complications and need for revision, with a shorter hospital stay. A statistically significant difference emerged for the hematoma rate (P = .0079). Monolateral flap should to be preferred because with the same coverage effectiveness, it guarantees the saving of controlateral muscle with its functionality and the possibility of its use in case of failure. Furthermore, as the technique is less invasive, it can be reserved for more fragile patients.

Keywords: negative pressure therapy, pectoralis major muscle flap, sternal wound infection

1. INTRODUCTION

Open‐heart surgery can be followed by different complications, as the Sternal Wound Dehiscence (SWD) that usually occurs after infection.

The first classification of these wounds was described by Pairolero & Arnold in 1984.1 Nowadays, according to the Center for Disease Control and Prevention (CDC), the Sternal Wound Infection (SWI) in surgical wounds after sternotomy should be classified into three types: superficial (SSWI), when it involves skin, and subcutaneous tissue until muscle fascia; deep (DSWI), when the dehiscence reaches the sternal surface without affecting it but there may be sternal instability, osteomyelitis, and/or mediastinitis,2 which are the most serious cases.

SSWI occur in 1.1% to 6.7% of cases, whereas the incidence of DSWI ranges from 0.1% to 3.7%,3, 4, 5, 6 although it would reach up to 10%, according to other studies.7, 8, 9 The SSWI morbidity and mortality rate ranges from 0.5% to 8% and in DSWI it increases more than twice, up to 47%.10, 11 In addition to high morbidity and mortality rates, SWIs are associated with prolonged periods of hospitalisation and high healthcare costs.12, 13, 14, 15, 16

The most commonly reported risk factors for DSWI include surgical technique, obesity, diabetes mellitus, prolonged stay in intensive care, emergent or urgent surgery, use of BIMA (bilateral internal mammary artery), reoperation, substernal seroma or haematoma, female gender.17, 18, 19, 20, 21

The most common pathogens detected in DSWI are Staphylococcus aureus, especially methicillin‐resistant species, followed by Gram‐negative as Pseudomonas aeruginosa, Klesbiella Pneumoniae, or Enterobacter spp. with increasing incidence and multidrug resistance.22

There are several methods for the treatment of SWIs and the most commonly used procedures are closed suction antibiotic catheter irrigation systems, Negative Pressure Therapy (NPT), and various flap coverages.10

“Conventional” treatment provides debridement and secondary closure or closed catheter irrigation. This choice is associated with mortality rate between 5% and 80%.23, 24 In the last years, radical debridement with the use of vascularized flaps reduced the mortality rate to 4.8% to 10.5%25, 26, 27, 28, 29: in the most cases Pectoralis Major, Rectus Abdominis, and Latissimus Dorsi muscle flaps represent the main choices for SWIs surgical coverage and infection control. Nowadays, NPT is an accepted method for the treatment of open contaminated/infected‐acute/chronic wounds. It reduces the wound bacterial colonisation rate, swelling and exudation, stimulates growth of granulation tissue, improves perfusion and antibiotic circulation in the wound, and creates favourable microenvironment for wound healing.30, 31, 32, 33, 34, 35, 36 The growing experience with the NPT pointed out how it can be used as a bridge to allow cleaning and preparation of the wound bed for further reconstructions.36, 37, 38 Traditionally, the timing for the surgical closure procedure is guided by the patient's general condition, the clinical appearance of the wound, the cultures performed on the wound bed, and laboratory tests, such as the CRP.39

The whole treatment of DSWI often involves prolonged hospitalisation/time in the Intensive Care Unit (ICU), prolonged antibiotic therapy, and high costs.12, 13, 14, 15, 16

In this study, we want to report the results we obtained from the comparison of two groups of patients with DSWI, following a multistep protocol: the first group was treated with preoperative NPT (VAC® therapy) and subsequent reconstruction with a Monolateral Pectoralis Major muscle Flap (MPMF), whereas the second one was managed with preoperative VAC‐therapy and a Bilateral Pectoralis Major muscle Flap (BPMF).

2. MATERIALS AND METHODS

2.1. Patients

From January 2014 to April 2018, a single‐centre retrospective study was performed and 167 patients with poststernotomy DSWI following cardiac surgery.

All patients were treated with a multistep protocol. The first step was the preoperative VAC‐therapy, performed in all 167 patients. The second step was surgery and two study groups were created: patients in Group A were treated with MPMF, whereas patients in Group B were treated with BPMF.

Both demographical data and surgical data were assessed routinely from all patients.

2.2. Surgical technique

Preoperative management of DSWI was the debridement time and NPT (V.A.C. ATS Therapy System, KCI Concepts, Inc, San Antonio, TX) in all 167 patients (Figures 1, 2, 3). Before aseptic procedures, wound cultures were performed for microbiological exam and antibiogram. Debridement involved the review of the wound margins and the removal of necrotic and infected tissue, with a copius irrigation of the wound bed through a hydrogen peroxide plus normal saline solution. Staples and non‐viable bone were removed with possible sequestrectomy, sternectomy, and a partial costectomy. At the beginning, all patients received empirical antibiotic treatment, then the therapy was based on the cultures and antibiograms.

Figure 1.

Figure 1

Preoperative time: sternal wound infection with closed drainage

Figure 2.

Figure 2

First step: surgical debridement

Figure 3.

Figure 3

VAC‐therapy placement

At the end of this time, the polyurethane‐customized foam was placed in the wound with a “two‐layer” technique, in order to completely cover the upper layers of the wound. The two foams were covered with sterile drape and the layers were connected to the tube through a central and superficial hole. The effective negative pressure set was at −125 mmHg. VAC‐therapy was replaced at least twice a‐week and at each change, microbiological cultures were performed.

At the subsequent surgical time, the MPMF (Group A) was raised as the standard procedure (Figure 4). The muscle monolateral flap was placed upon the sternal defect and fixated without tension. Closure was performed in a multilayer technique using 2‐0 and 3‐0 absorbable single stitches sutures (Vicryl®, Ethicon, Norderstedt, Germany) for the subcutaneous tissue and same calibres non‐absorbable (Ethilon®, Ethicon, Norderstedt, Germany) single vertical mattress sutures for the skin (Figure 5). In Group B, both Pectoralis muscles were sharply elevated from their costal and sternal insertions, continuing the dissection in a subpectoral plane to allow bilateral advancement to the midline without tension. The humeral attachments of the Pectoralis muscles were left intact and the thoracoacromial arteries were carefully preserved. The insertion of the Pectoralis muscles was released with preservation of the long thoracic artery to aid in a tension‐free closure. The Pectoralis muscles were imbricated medially. Closure was performed in a multilayer technique.

Figure 4.

Figure 4

Second step: unilateral Pectoralis Major muscle flap coverage

Figure 5.

Figure 5

Postoperative picture at 30 days after surgery

Two or three drains were used and the wounds were taped with sterile non‐woven tape.

2.3. Statistical analysis

Statistical analysis was performed using the SPSS software. Fisher's exact two‐tailed test was used to compare postoperative complications (seroma, haematoma, dehiscence, surgical revision). A P‐value of 0.05 was considered statistically significant.

3. RESULTS

3.1. Patient characteristics

From January 2014 to April 2018, 167 patients had a DSWI following cardiac surgery with sternotomy. CABG (Coronary Artery Bypass Grafting) was performed in 109 patients (65.2%), valve replacement procedure in 26 patients (15.5%), both these procedures in 31 patients (18.5%); 1 patient (<1%) was treated for an ascending aorta rupture with intramural hematoma and hemopericardium. Bilateral Internal Mammary Artery technique for revascularization was used in 51 cases (30.5%) and other 51 patients underwent emergent/urgent surgery. Sex distribution, mean age, BMI, and comorbidities are described in Table 1.

Table 1.

Patient's characteristics and comorbidities

Sex (M:F) (97:70)
Age (mean) 67.1
BMI > 30 73 (43.7%)
Diabetes mellitus 61 (36.5%)
Heart failure 41 (24.5%)
COPD 20 (11.9%)
CRI 21 (12.5%)
Hypertension 89 (53.2%)
Hyperlipidaemia 81 (48.5%)
Smoke 100 (59.8%)

Abbreviations: BMI, body mass index; COPD, chronic obstructive polmunary desease; CRI, chronic renal insufficiency.

Wound coltures were performed before VAC placing. In most patients a positivity for Gram + cocci was found: Staphylococcus epidermidis in 58 patients (34.7%); Staphylococcus aureus in 95 patients (56.8%), including 34 positive for Pseudomonas, KPC, Candida albicans too; 12 coltures were positive for Enterobacter (7.18%); in two cases, the presence of other pathogens was found. VAC‐therapy lasted 16 ± 6 days.

Two homogeneous groups were created before the reconstructive time. Group A included 86 patients (51.5%) that underwent MPMF. Group B included the remaining 81 patiens (48.5%) that underwent BPMF.

In Group A 14 adverse events (16.27%) occurred, whereas 30 complications (37.03%) occurred in Group B; wound revision was needed in eight cases and in 14 cases, for Groups A and B, respectively (Table 2). In each group, one patient had mediastinitis and died for sepsis (Group A) and for Heart Failure (Group B). Other two mediastinitis occurred and the one of Group B had sepsis.

Table 2.

Complication and revision rate

Group A Group B
Haematoma, n (%) 1 (1.2%) 9 (11.1%)
Seroma, n (%) 6 (7%) 13 (16%)
Deishences, n (%) 7 (8.1%) 8 (9.9%)
Revision needed, n (%) 8 (9.3%) 14 (17.3%)

When needed, the mean time spent in ICU was 3.2 ± 1.6 days in Group A and 18 ± 13 in Group B. The mean hospitalisation time was 18.1 ± 14.5 days for MP patients and 32 ± 24.2 for BP patients.

4. DISCUSSION

Deep sternal wound infections (DSWI) are a serious complication occurring in about 0.1% to 3.7% of patients after sternotomy for cardiothoracic surgery.3, 4, 5, 6

The first classification of these wounds was described by Pairolero & Arnold in 1984.1 They classified these infections according to the postoperative onset timing. In 1996, Oakley et al used the same criteria but added to their classification the presence of clinical risk factors.40 One year later, Jones et al proposed the first classification based on the affected anatomical site in addition to the ever presence of infection as the main parameter.41 Finally, in 2007 Greig et al defined the only affected anatomical site classification.42 In 2015, Anger et al suggested a new classification based on anatomical changes, considering the depth and location of the surgical wound.43

There are various risk factors, like surgical technique and the use of accurate asepsis procedures, female gender, high BMI, diabetes mellitus and hyperglycemia status, prolonged stay in intensive care, emergent or urgent surgery, use of BIMA (bilateral internal mammary artery), and others, like age > 70, reoperation, heart failure, renal failure, peripheral vascular disease, need for transfusion or prolonged inotropic support, smoking, chronic obstructive pulmonary disease, substernal seroma, or haematoma.17, 18, 19, 20, 21

The most common pathogens detected in DSWI are Staphylococcus aureus, Pseudomonas aeruginosa, Klesbiella Pneumoniae, or Enterobacter spp. The incidence of MRSA and multidrug resistance Gram‐negative species is increasing in the last years.22

In the past the treatment only consisted in intravenous antibiotics and different surgical tecniques, but it was associated with a high short‐ and long‐term mortality.44

The introduction of negative pressure therapy in the treatment of difficult wounds dates back to 1997 by Argenta and Morykwas,37 but Obdeijn suggested its application in post‐sternotomy wound dehiscences in 1999.45 In these cases VAC‐therapy leads to a faster wound healing,46, 47, 48 lower length of hospital stay and the subsequent lower in‐hospital cost.38 Moreover, early studies and meta‐analysis showed that VAC‐therapy is associated with lower mortality than other surgical techniques in DSWI38, 49, 50 and that it is a good choice of treatment for these complications when it is used with other concomitant surgical reconstructive procedures.51 There are no controindications in using VAC‐therapy in SWI, but all free particles in the sternum have to be removed completely before its placing, in order to avoid severe bleeding caused by the displacement of the fragments in the vessels.52

Primary or delayed flap closure is generally obtained by myocutaneous flaps (myoplasty), such as the Pectoralis Major flap,53, 54, 55, 56, 57 the Rectus Abdominis flap,58, 59 the LD flap (Latissimus Dorsi muscle),60 or the omental flap.61, 62

Pectoralis Major and Rectus Abdominis are the first‐line flaps, with the preference of the first one.27, 56, 63

Rectus Abdominis flap can be used especially in dehiscences of the lower III of the sternum, alone or in combination with the Pectoralis Major muscle flap. The flap is based on the peduncle of the superior epigastric artery, so the use of the internal mammary artery (IMA) for the previous cardiac revascularization is at least a relative contraindication,64, 65 although cases of flap survival have been described despite the absence of one or both te IMA61, 66, 67, 68: this is explained by the presence of collateral circles based on the musculofrenic arteries and on the anterior intercostal arteries. A possible complication associated with this flap is the formation of herniations through the abdominal wall.69

The LD flap can be used to cover dehiscence of the two upper thirds of the sternum. Vascularization is based on the thoraco‐dorsal artery. The main advantage is related to the savings of the collateral blood supply to the sternum and parasternal tissues; the disadvantages are the possible formation of seromas in the donor site and the need to change the position of the patient to lateral decubitus during surgery.70

The greater Omentum flap is based on the gastroepiploic arteries and can cover large dehiscences, even of the entire sternum.63, 71 Its harvesting requires a laparotomic incision or less invasive abdominal incisions, so it is contraindicated in complicated patients; furthermore, cases of accidental damage to abdominal viscera and formation of abdominal hernias have been described.1 Laparoscopy can reduce all of these risks, but it is still a little used approach.59 It would be advisable to exclude neoplastic pathologies at least of the colon because the omentum can be the site of metastatic repetition: in fact, Telfer et al72 described the case of a patient, who underwent the transposition of the Greater Omentum with the onset of an omental adenocarcinoma at the sternal region, starting from a colon cancer.

Pectoralis Major muscle flap is the technique of choice for several centres. One or both of the Pectoralis muscles can be harvested and the decision is based on the kind and extension of the area to be covered. Furthermore, in right‐handed patients the left pectoral muscle is the first choice, so that the functionality of the dominant limb is completely preserved; equally, the right muscle is used in left‐handed people.

The dominant peduncle is the thoracoacromial artery, therefore the use of the IMA for the revascularization procedure is an independent factor.59, 73 The flap is an excellent option, especially for the covers of the two upper thirds of the sternum41, 69, 74 and guarantees a good thoracic stabilisation, a good aesthetic result and the maintenance of respiratory function.54, 75, 76, 77

MPMF is an alternative that spares the contralateral Pectoralis Major muscle. The technique is comparable to BPMF in terms of effectiveness of coverage and mortality, but it is associated with shorter surgical times and less invasiveness, morbidity, and complications, so as to have an indication even for patients with more risk factors.78

In both procedures, the main limitation is the difficulty in covering the lower III of the sternum26, 41, 74: in these cases, they can associate other flaps or reinforce the lower part of the flap with the suture of the only fascia of the Rectus Abdominis muscle.79 The main complications are hematoma, seroma, infection, and dehiscence. In the literature, the incidence of these complications varies from study to study, especially based on the characteristics of the sample populations.41, 73, 80 The incidence of seromas and hematomas is around 6% to 7%; the re‐infection rate is around 12%; the recurrence of sternal dehiscences is generally <10%, although it can even reach 27%, especially for the partial dehiscences of the lower part of the sternum, where the tension after the coverage with the flap is high.1, 41, 68, 70, 71, 72, 81, 82

In our study, the overall complication rate is 16.2% in Group A and 37% in Group B. The rate of postoperative hematomas and seromas is lower after MPMF compared to BPMF: in Group A, the percentage of hematomas and seromas are 1.2% and 7%, respectively, instead in Group B they are 11.1% and 16%. Consequently, the need for surgical revision in patients treated with BPMF is higher compared to MPMF patients (17.3% versus 9.3%). Our results confirm the rate of dehiscence recurrence after PMF reported in the literature (<10% in both groups). A statistically significant difference emerged only for the hematoma rate (P = .0079). The mean time in ICU and the overall hospitalisation time are shorter in Group A (3.2 ± 1.6, and 18.1 ± 14.5 days) than in Group B (18 ± 13 and 32 ± 24.2 days). Mortality rate was <1.2% after both procedures.

Our study shows that the coverage with unilateral or bilateral Pectoralis Major muscle flap is equally effective and without significant differences on the infectious outcome. On the other hand, the unilateral technique is less invasive because it saves the contralateral muscle with its functionality, so it can be reserved for more fragile patients. The contralateral Pectoralis muscle is always available in cases of recurrences. Furthermore, MPBF is associated with a more rapid postoperative course, with fewer days of hospitalisation, lower complication rate, and lower healthcare costs. In conclusion, both techniques are the first choice and, when conditions allow, unilateral flap is preferred.

CONFLICT OF INTEREST

The authors declare no conflicts of interest.

AUTHOR CONTRIBUTIONS

All the authors and no one else contributed to the writing of the work.

ACKNOWLEDGMENTS

No contributions, technical help, financial and material support were provided by “V.A.C. ATS Therapy System, KCI Concepts, Inc, San Antonio, TX” or by others.

Lo Torto F, Turriziani G, Donato C, et al. Deep sternal wound infection following cardiac surgery: A comparison of the monolateral with the bilateral pectoralis major flaps. Int Wound J. 2020;17:683–691. 10.1111/iwj.13324

REFERENCES

  • 1. Pairolero PC, Arnold PG. Management of recalcitrant median sternotomy wounds. J Thorac Cardiovasc Surg. 1984;88(3):357‐364. [PubMed] [Google Scholar]
  • 2. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control. 1988;16(3):128‐140. [DOI] [PubMed] [Google Scholar]
  • 3. Ridderstolpe L, Gill H, Granfeldt H, Ahlfeldt H, Rutberg H. Superficial and deep sternal wound complications: incidence, risk factors and mortality. Eur J Cardiothorac Surg. 2001;20:1168‐1175. [DOI] [PubMed] [Google Scholar]
  • 4. Schimmer C, Reents W, Berneder S, et al. Prevention of sternal dehiscence and infection in high‐risk patients: a prospective randomized multicenter trial. Ann Thorac Surg. 2008;86:1897‐1904. [DOI] [PubMed] [Google Scholar]
  • 5. Baillot R, Cloutier D, Montalin L, et al. Impact of deep sternal wound infection management with vacuum‐assisted closure therapy followed by sternal osteosynthesis: a 15‐year review of 23,499 sternotomies. Eur J Cardiothorac Surg. 2010;37:880‐887. [DOI] [PubMed] [Google Scholar]
  • 6. Farsky PS, Graner H, Duccini P, et al. Risk factors for sternal wound infections and application of the STS score in coronary artery bypass graft surgery. Rev Bras Cir Cardiovasc. 2011;26(4):624‐629. [DOI] [PubMed] [Google Scholar]
  • 7. Landes G, Harris PG, Sampalis JS, et al. Outcomes in the management of sternal dehiscence by plastic surgery: a ten‐year review in one university center. Ann Plast Surg. 2007;59(6):659‐666. [DOI] [PubMed] [Google Scholar]
  • 8. Finkelstein R, Rabino G, Mashiah T, et al. Surgical site infection rates following cardiac surgery: the impact of a 6‐year infection control program. Am J Infect Control. 2005;33(8):450‐454. [DOI] [PubMed] [Google Scholar]
  • 9. Cove ME, Spelman DW, MacLaren G. Infectious complications of cardiac surgery: a clinical review. J Cardiothor Vasc Anesth. 2012;26(6):1094‐1100. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. Kimberly S, Anderson E, Harper JG. Overview and management of sternal wound infection. Semin Plast Surg. 2011;25(1):25‐33. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11. Braxton M, Marrin CA, McGrath PD, et al. 10‐year follow‐up of patients with and without mediastinitis. Semin Thor Cardiovasc Surg. 2004;16(1):70‐76. [DOI] [PubMed] [Google Scholar]
  • 12. Mokhtari A, Sjogren J, Nilsson J, Gustafsson R, Malmsjo M, Ingemansson R. The cost of vacuum assisted closure therapy in treatment of deep sternal wound infections. Scand Cardiovasc J. 2008;42:85‐89. [DOI] [PubMed] [Google Scholar]
  • 13. Lucet JC, Batisse D, Brucker G. Mediastinitis after sternotomy. Mortality and hospital length of stay. Groupe parisien detude des sternotomies. Arch Mal Coeur Vaiss. 1997;90:471‐475. [PubMed] [Google Scholar]
  • 14. Loop FD, Lytle BW, Cosgrove DM, et al. J. Maxwell Chamberlain memorial paper. Sternal wound complications after isolated coronary artery bypass grafting: early and late mortality, morbidity, and cost of care. Ann Thorac Surg. 1990;49:179‐186. discussion 186–7. [DOI] [PubMed] [Google Scholar]
  • 15. Taylor AH, Mitchell AE, Mitchell IM. A 15‐year study of the changing demographics and infection risk in a new UKcardiac surgery unit. Interact Cardiovasc Thorac Surg. 2012;15:390‐394. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16. Graf K, Ott E, Vonberg RP, Kuehn C, Haverich A, Chaberny IF. Economic aspects of deep sternal wound infections. Eur J Cardiothorac Surg. 2010;37:893‐896. [DOI] [PubMed] [Google Scholar]
  • 17. Omran AS, Karimi A, Ahmadi SH, et al. Superficial and deep sternal wound infection after more than 9000 coronary artery bypass graft (CABG): incidence, risk factors and mortality. BMC Infect Dis. 2007;7(1):1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18. Parisian Mediastinitis Study Group . Risk factors for deep sternal wound infection after sternotomy: a prospective, multicenter study. J Thor Cardiovasc Surg. 1996;111(6):1200‐1207. [DOI] [PubMed] [Google Scholar]
  • 19. Cotogni P, Barbero C, Rinaldi M. Deep sternal wound infection after cardiac surgery: evidences and controversies. World J Crit Care Med. 2015;4(4):265‐273. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20. Borger MA, Rao V, Weisel RD, et al. Deep sternal wound infection: risk factors and outcomes. Ann Thorac Surg. 1998;65(4):1050‐1056. [DOI] [PubMed] [Google Scholar]
  • 21. Heilmann C, Stahl R, Schneider C, et al. Wound complications after median sternotomy: a single‐Centre study. Interact Cardiovasc Thorac Surg. 2013;16(5):643‐648. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22. Morgante A, Romeo F. Deep sternal wound infections: a severe complication after cardiac surgery. G Chir. 2017;38(1):33‐36. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23. Sarr MG, Gott VL, Townsend TR. Mediastinal infection after cardiac surgery. Ann Thorac Surg. 1984;38:415‐423. [DOI] [PubMed] [Google Scholar]
  • 24. Bryant LR, Spencer FC, Trinkle JK. Treatment of median sternotomy infection by mediastinal irrigation with an antibiotic solution. Ann Surg. 1969;169:914‐920. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25. Carlesimo B, Lo Torto F, Rossi A, Marcasciano M, Ruggiero M. Long‐term result of bilateral pectoralis major muscle advancement flap in median sternotomy wound infections. Eur Rev Med Pharmacol Sci. 2014;18:3767‐3772. [PubMed] [Google Scholar]
  • 26. Jurkiewicz MJ, Bostwick J III, Hester TR, Bishop JB, Craver J. Infected median sternotomy wound. Successful treatment by muscle flaps. Ann Surg. 1980;191:738‐744. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27. Pairolero PC, Arnold PG, Harris JB. Long‐term results of pectoralis major muscle transposition for infected sternotomy wounds. Ann Surg. 1991;213:583‐589. discussion 589–590. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28. Parisi P, Lo Torto F, Carlesimo B, Ribuffo D, Scuderi N. The split pectoralis flap: combining the benefits of pectoralis major advancement and turnover techniques in one flap. Plast Reconstr Surg. 2018;141(1):191e‐192e. [DOI] [PubMed] [Google Scholar]
  • 29. Fioramonti P, Sorvillo V, Maruccia M, et al. New application of purse string suture in skin cancer surgery. Int Wound J. 2018;15(6):893‐899. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30. Lo Torto F, Ruggiero M, Parisi P, Borab Z, Sergi M, Carlesimo B. The effectiveness of negative pressure therapy on infected wounds: preliminary results. Int Wound J. 2017;14(6):909‐914. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31. Lo Torto F, Turriziani G, Miraldi F, Carlesimo B, Ribuffo D. Vacuum‐assisted closure therapy for the treatment of poststernotomy wound dehiscence in neonates and infants. Thorac Cardiovasc Surg. 2019. 10.1055/s-0039-1688958. [Epub ahead of print]. [DOI] [PubMed] [Google Scholar]
  • 32. Marcasciano M, Cavalieri E, Kaciulyte J, et al. Temporary, customized negative pressure wound therapy to assist wound closure in selected patients: a practical solution or a bridge to advanced care. Wound Repair Regen. 2019;27(6):720‐721. [DOI] [PubMed] [Google Scholar]
  • 33. Lo Torto F, Monfrecola A, Kaciulyte J, et al. Preliminary result with incisional negative pressure wound therapy and pectoralis major muscle flap for median sternotomy wound infection in a high‐risk patient population. Int Wound J. 2017;14(6):1335‐1339. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34. Yoshimoto A, Inoue T, Fujisaki M, Morizumi S, Suematsu Y. Efficacy of vacuum‐assisted closure therapy on rehabilitation during the treatment for surgical site infection after cardiovascular surgery. Gen Thorac Cardiovasc Surg. 2016;64(8):464‐9. [DOI] [PubMed] [Google Scholar]
  • 35. Simek M, Nemec P, Zalesak B, et al. Vacuum‐assisted closure in the treatment of sternal wound infection after cardiac surgery. Biomed Pap. 2007;151(2):295‐299. [DOI] [PubMed] [Google Scholar]
  • 36. Fleck TM, Fleck M, Moidl R, et al. The vacuum‐assisted closure system for the treatment of deep sternal wound infections after cardiac surgery. Ann Thorac Surg. 2002;74(5):1596‐1600. [DOI] [PubMed] [Google Scholar]
  • 37. Argenta LC, Morykvas MJ, Marks MW, et al. Vacuum‐assisted closure: state of art. Plast Reconstruct Surg. 2006;117:127‐42S. [DOI] [PubMed] [Google Scholar]
  • 38. Sjoegren J, Gustafsson R, Nilsson J, Malmsjoe M, Ingemansson R. Clinical outcome after poststernotomy mediastinitis: vacuum‐assisted closure versus conventional treatment. Ann Thorac Surg. 2005;79:2049‐2055. [DOI] [PubMed] [Google Scholar]
  • 39. Gustafsson RI, Johnsson P, Algotsson L, Blomquist S, Ingemansson R. Vacuum‐assisted closure therapy guided by C‐reactive protein level in patients with deep sternal wound infection. J Thorac Cardiovasc Surg. 2002;123:895‐900. [DOI] [PubMed] [Google Scholar]
  • 40. El Oakley RM, Wright JE. Postoperative mediastinitis: classification and management. Ann Thorac Surg. 1996;61(3):1030‐1036. [DOI] [PubMed] [Google Scholar]
  • 41. Jones G, Jurkiewicz MJ, Bostwick J, et al. Management of the infected median sternotomy wound with muscle flaps. The Emory 20‐year experience. Ann Surg. 1997;225(6):766‐776. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42. Greig AV, Geh JL, Khanduja V, Shibu M. Choice of flap for the management of deep sternal wound infection—an anatomical classification. J Plast Reconstr Aesthet Surg. 2007;60(4):372‐378. [DOI] [PubMed] [Google Scholar]
  • 43. Anger J, Dantas DC, Arnoni RT, Farsky PS. A new classification of post‐sternotomy dehiscence. Rev Bras Cir Cardiovasc. 2015;30(1):114‐118. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44. Toumpoulis IK, Anagnostopoulos CE, Derose JJ Jr, Swistel DG. The impact of deep sternal wound infection on long‐term survival after coronary artery bypass grafting. Chest. 2005;127:464‐471. [DOI] [PubMed] [Google Scholar]
  • 45. Obdeijn MC, de Lange MY, Lichtendahl DH, de Boer WJ. Vacuum‐assisted closure in the treatment of poststernotomy mediastinitis. Ann Thorac Surg. 1999;68(6):2358‐2360. [DOI] [PubMed] [Google Scholar]
  • 46. Joseph E, Hamori CA, Bergman S, Roaf E, Swann NF, et al. A prospective randomized trial of vacuum‐assisted closure versus standard therapy of chronic non‐healing wounds. Wounds. 2000;12:60‐67. [Google Scholar]
  • 47. Vuerstaek JD, Vainas T, Wuite J, Nelemans P, Neumann MH, et al. State‐of‐the‐art treatment of chronic leg ulcers: a randomized controlled trial comparing vacuum‐assisted closure (V.A.C.) with modern wound dressings. J Vasc Surg. 2006;44:1029‐1037. discussion 1038.7. [DOI] [PubMed] [Google Scholar]
  • 48. Catarino PA, Chamberlain MH, Wright NC, et al. High‐pressure suction drainage via a polyurethane foam in the management of poststernotomy mediastinitis. Ann Thorac Surg. 2000;70:1891‐1895. [DOI] [PubMed] [Google Scholar]
  • 49. Sjogren J, Nilsson J, Gustafsson R, Malmsjo M, Ingemansson R. The impact of vacuum‐assisted closure on long‐term survival after post‐sternotomy mediastinitis. Ann Thorac Surg. 2005;80:1270‐1275. [DOI] [PubMed] [Google Scholar]
  • 50. Falagas ME, Tansarli GS, Kapaskelis A, Vardakas KZ. Impact of vacuum‐assisted closure (VAC) therapy on clinical outcomes of patients with sternal wound infections: a meta‐analysis of non‐randomized studies. PLoS One. 2013;8(5):e64741. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51. Listewnik MJ, Sielicki P, Mokrzycki K, Biskupski A, Brykczyński M. The use of vacuum‐assisted closure in purulent complications and difficult‐to‐heal wounds in cardiac surgery. Adv Clin Exp Med. 2015;24(4):643‐650. [DOI] [PubMed] [Google Scholar]
  • 52. Kiessling AH, Lehmann A, Isgro F, Moritz A. Tremendous bleeding complication after vacuum‐assisted sternal closure. J Cardiothorac Surg. 2011;6:16. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53. Daya M, Barnes N. Use of VAC therapy and sternal plating in the treatment of sternotomy wound dehiscence. Eur J Plast Surg. 2009;32:287‐291. [Google Scholar]
  • 54. Klesius AA, Dzemali O, Simon A, et al. Successful treatment of deep sternal infections following open heart surgery by bilateral pectoralis major flaps. Eur J Cardiothorac Surg. 2004;25:218‐223. [DOI] [PubMed] [Google Scholar]
  • 55. Netscher DT, Eladoumikdachi F, Mchugh PM, Thornby J, Soltero E. Sternal wound debridement and muscle flap reconstruction: functional implications. Ann Plast Surg. 2003;51:115‐122. [DOI] [PubMed] [Google Scholar]
  • 56. Ringelman PR, Vander Kolk CA, Cameron D, Baumgartner WA, Manson PN. Long‐term results of flap reconstruction in median sternotomy wound infections. Plast Reconstr Surg. 1994;93:1208‐1214. [PubMed] [Google Scholar]
  • 57. Wong CH, Senewiratne S, Garlick B, Mullany D. Two‐stage management of sternal wound infection using bilateral pectoralis major advancement flap. Eur J Cardiothorac Surg. 2006;30:148‐152. [DOI] [PubMed] [Google Scholar]
  • 58. Yuen JC, Zhou AT, Serafin D, Georgiade GS. Longterm sequelae following median sternotomy wound infection and flap reconstruction. Ann Plast Surg. 1995;35:585‐589. [DOI] [PubMed] [Google Scholar]
  • 59. Davison SP, Clemens MW, Armstrong D, Newton ED, Swartz W. Sternotomy wounds: rectus flap versus modified pectoral reconstruction. Plast Reconstr Surg. 2007;120(4):929‐934. [DOI] [PubMed] [Google Scholar]
  • 60. Erdmann D, Küntscher M, Petracic A, et al. Plastic surgery coverage of osteocutaneous defects of the sternum area with the vertical and transversal rectus abdominis muscle (VRAM/TRAM) flap. Chirurg. 2000;71:1156‐1160. [DOI] [PubMed] [Google Scholar]
  • 61. Nahai F, Rand RP, Hester TR, Bostwick J III, Jurkiewicz MJ. Primary treatment of the infected sternotomy wound with muscle flaps: a review of 211 consecutive cases. Plast Reconstr Surg. 1989;84:434‐441. [DOI] [PubMed] [Google Scholar]
  • 62. Lee ABJR, Schimert G, Shaktin S, Seigel JH. Total excision of the sternum and thoracic pedicle transposition of the greater omentum; useful strategems in managing severe mediastinal infection following open heart surgery. Surgery. 1976;80:433‐436. [PubMed] [Google Scholar]
  • 63. Hultman CS, Culbertson JH, Jones GE, et al. Thoracic reconstruction with the omentum: indications, complications, and results. Ann Plast Surg. 2001;46:242‐249. [DOI] [PubMed] [Google Scholar]
  • 64. Arnold PG, Pairolero PC. Use of pectoralis major muscle flaps to repair defects of the anterior chest wall. Plast Reconstr Surg. 1979;63(2):205‐213. [DOI] [PubMed] [Google Scholar]
  • 65. Solomon MP, Granick MS. New reconstruction method for sternotomy wounds. Perspect Plast Surg. 1994;8(1):61‐65. [Google Scholar]
  • 66. Fernando B, Muszynski C, Mustoe T. Closure of a sternal deficit with the rectus abdominis muscle after sacrifice of both internal mammary arteries. Ann Plast Surg. 1988;21:468‐471. [DOI] [PubMed] [Google Scholar]
  • 67. Arnold PG, Pairolero PC. Chest‐wall reconstruction: an account of 500 consecutive patients. Plast Reconstr Surg. 1996;98:804‐810. [DOI] [PubMed] [Google Scholar]
  • 68. Netscher DT, Eladoumikdachi F, Goodman CM. Rectus abdominis muscle flaps used successfully for median sternotomy wounds after ipsilateral internal mammary artery ligation. Ann Plast Surg. 2001;47:223‐228. [DOI] [PubMed] [Google Scholar]
  • 69. Lee C‐H, Hsien J‐H, Tang Y‐B, Chen H‐C. Reconstruction for sternal osteomyelitis at the lower third of sternum. J Plast Reconstr Aesthet Surg. 2010;63(4):633‐641. [DOI] [PubMed] [Google Scholar]
  • 70. Dejesus RA, Paletta JD, Dabb RW. Reconstruction of the median sternotomy wound dehiscence using the latissimus dorsi myocutaneous flap. J Cardiovasc Surg (Torino). 2001;42(3):359‐364. [PubMed] [Google Scholar]
  • 71. López‐Monjardin H, de‐la‐Peña‐Salcedo A, Mendoza‐Muñoz M, López‐Yáñez‐de‐la‐Peña A, Palacio‐López E, López‐García A. Omentum flap versus pectoralis major flap in the treatment of mediastinitis. Plast Reconstr Surg. 1998;101(6):1481‐1485. [DOI] [PubMed] [Google Scholar]
  • 72. Telfer JR, Chapple DC, Powell BW. Metastatic colonic adenocarcinoma in a pedicled omental flap used for sternal reconstruction: a case report. Br J Plast Surg. 1996;49:67‐69. [DOI] [PubMed] [Google Scholar]
  • 73. Ascherman JA, Patel SM, Malhotra SM, Smith CR. Management of Sternal Wounds with bilateral Pectoralis major Myocutaneous advancement flaps in 114 consecutively treated patients: refinements in technique and outcomes analysis. Plast Reconstr Surg. 2004;114(3):676‐683. [DOI] [PubMed] [Google Scholar]
  • 74. Nahai F, Morales L, Bone DK, Bostwick J. Pectoralis major muscle turnover flaps for closure of the infected sternotomy wound with preservation of form and function. Plast Reconstr Surg. 1982;70(4):471‐474. [DOI] [PubMed] [Google Scholar]
  • 75. Bagheri R, Tashnizi MA, Haghi SZ, et al. Therapeutic outcomes of pectoralis major muscle turnover flap in mediastinitis. Korean J Thorac Cardiovasc Surg. 2015;48(4):258‐264. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 76. Zeitani J, Pompeo E, Nardi P, et al. Early and long‐term results of pectoralis muscle flap reconstruction versus sternal rewiring following failed sternal closure. Eur J Cardiothorac Surg. 2013;43(6):e144‐e150. [DOI] [PubMed] [Google Scholar]
  • 77. Jang YJ, Park MC, Park DH, Lim H, Kim JH, Lee IJ. Immediate debridement and reconstruction with a pectoralis major muscle flap for poststernotomy mediastinitis. Arch Plast Surg. 2012;39(1):36‐41. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 78. Fernández‐Palacios J, Abad C, García‐Duque O, Baeta PJ. Postoperative mediastinitis in open heart surgery patients. Treatment with unilateral or bilateral pectoralis major muscle flap? J Cardiovasc Surg (Torino). 2010;51(5):765‐771. [PubMed] [Google Scholar]
  • 79. Sauvageau J, Gagnon AR, Nikolis A, Harris PG, Brutus JP, Cordoba C. The pedicled rectus abdominis muscle transposition flap, as an adjunct to the unilateral pectoralis major Island flap, to reconstruct a full length sternal defect after postoperative mediastinal wound infection. J Plast Reconstr Aesthet Surg. 2008;61(2):230‐231. [DOI] [PubMed] [Google Scholar]
  • 80. Zahiri HR, Lumpkins K, Kelishadi SS, et al. Significant predictors of complications after sternal wound reconstruction. Ann Plast Surg. 2012;69(4):439‐441. [DOI] [PubMed] [Google Scholar]
  • 81. Solomon MP, Granick MS. Bipedicle muscle flaps in sternal wound repair. Plast Reconstr Surg. 1998;101:356‐360. [DOI] [PubMed] [Google Scholar]
  • 82. Mathes SJ. The principles of muscle and musculocutaneous flaps. In: McCarthy JG, ed. Plastic Surgery. Vol 1. Philadelphia, PA: Saunders; 1990. [Google Scholar]

Articles from International Wound Journal are provided here courtesy of Wiley

RESOURCES